191 related articles for article (PubMed ID: 19524576)
1. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.
Li H; Fan X; Stoicov C; Liu JH; Zubair S; Tsai E; Ste Marie R; Wang TC; Lyle S; Kurt-Jones E; Houghton J
Gastroenterology; 2009 Sep; 137(3):934-44, 944.e1-4. PubMed ID: 19524576
[TBL] [Abstract][Full Text] [Related]
2. Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells.
Li H; Cai X; Fan X; Moquin B; Stoicov C; Houghton J
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G263-75. PubMed ID: 17991709
[TBL] [Abstract][Full Text] [Related]
3. [Killing effect of interleukin-18-enhanced FasL-expressing colon cancer cells on human hepatocytes in vitro].
Xu T; Hao XS; Ren XB; Zhang HL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):659-62. PubMed ID: 21122378
[TBL] [Abstract][Full Text] [Related]
4. Role of fas ligand in uveal melanoma-induced liver damage.
Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
[TBL] [Abstract][Full Text] [Related]
5. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.
Li X; Xu F; Karoopongse E; Marcondes AM; Lee K; Kowdley KV; Miao CH; Trobridge GD; Campbell JS; Deeg HJ
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1210-9. PubMed ID: 23707854
[TBL] [Abstract][Full Text] [Related]
8. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand upregulation is an early event in colonic carcinogenesis.
Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F
J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
12. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
13. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells.
Delmas D; Rébé C; Lacour S; Filomenko R; Athias A; Gambert P; Cherkaoui-Malki M; Jannin B; Dubrez-Daloz L; Latruffe N; Solary E
J Biol Chem; 2003 Oct; 278(42):41482-90. PubMed ID: 12902349
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.
Atsuta I; Liu S; Miura Y; Akiyama K; Chen C; An Y; Shi S; Chen FM
Stem Cell Res Ther; 2013; 4(5):111. PubMed ID: 24025590
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
[TBL] [Abstract][Full Text] [Related]
17. Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes.
Walter D; Schmich K; Vogel S; Pick R; Kaufmann T; Hochmuth FC; Haber A; Neubert K; McNelly S; von Weizsäcker F; Merfort I; Maurer U; Strasser A; Borner C
Hepatology; 2008 Dec; 48(6):1942-53. PubMed ID: 19003879
[TBL] [Abstract][Full Text] [Related]
18. Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations.
Liu K; McDuffie E; Abrams SI
J Immunol; 2003 Oct; 171(8):4164-74. PubMed ID: 14530339
[TBL] [Abstract][Full Text] [Related]
19. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
20. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion.
Yoong KF; Afford SC; Randhawa S; Hubscher SG; Adams DH
Am J Pathol; 1999 Mar; 154(3):693-703. PubMed ID: 10079247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
